These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8794787)

  • 21. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Sanchez-Urdazpal L; Czaja AJ; van Hoek B; Krom RA; Wiesner RH
    Hepatology; 1992 Feb; 15(2):215-21. PubMed ID: 1735524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis.
    Czaja AJ; Nishioka M; Morshed SA; Hachiya T
    Gastroenterology; 1994 Jul; 107(1):200-7. PubMed ID: 8020663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
    Czaja AJ; Davis GL; Ludwig J; Baggenstoss AH; Taswell HF
    Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals.
    Vento S; Guella L; Mirandola F; Cainelli F; Di Perri G; Solbiati M; Ferraro T; Concia E
    Lancet; 1995 Sep; 346(8975):608-9. PubMed ID: 7651006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and significance of antibodies to chromatin in autoimmune hepatitis.
    Czaja AJ; Shums Z; Binder WL; Lewis SJ; Nelson VJ; Norman GL
    Dig Dis Sci; 2003 Aug; 48(8):1658-64. PubMed ID: 12924665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and significance of antibodies to histones in autoimmune hepatitis.
    Czaja AJ; Ming C; Shirai M; Nishioka M
    J Hepatol; 1995 Jul; 23(1):32-8. PubMed ID: 8530807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of Japanese male patients with type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Sakaguchi K; Shiratori Y
    Aliment Pharmacol Ther; 2006 Aug; 24(3):519-23. PubMed ID: 16886918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of selected serologic markers in the diagnosis of autoimmune hepatitis].
    Marcinkiewicz M; Gryc E; Kreczko S
    Przegl Lek; 1998; 55(11):614-8. PubMed ID: 10216378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies.
    Hajoui O; Martin S; Alvarez F
    Clin Exp Immunol; 1998 Sep; 113(3):339-45. PubMed ID: 9737660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ; Rakela J; Hay JE; Moore SB
    Gastroenterology; 1990 Jun; 98(6):1587-93. PubMed ID: 2338197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1991 Jun; 66(6):572-82. PubMed ID: 1646353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis.
    Wood JR; Czaja AJ; Beaver SJ; Hall S; Ginsburg WW; Kaufman DK; Markowitz H
    Hepatology; 1986; 6(5):976-80. PubMed ID: 3758948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis.
    Czaja AJ; Shums Z; Donaldson PT; Norman GL
    Dig Dis Sci; 2004 Apr; 49(4):611-8. PubMed ID: 15185865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT; Lohse AW
    Am J Gastroenterol; 2002 Feb; 97(2):413-9. PubMed ID: 11866281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis.
    Löhr H; Treichel U; Poralla T; Manns M; Meyer zum Büschenfelde KH; Fleischer B
    Hepatology; 1990 Dec; 12(6):1314-20. PubMed ID: 2258147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies in autoimmune liver diseases.
    Sener AG
    APMIS; 2015 Nov; 123(11):915-9. PubMed ID: 26359647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic predispositions for the immunological features of chronic active hepatitis.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    Hepatology; 1993 Oct; 18(4):816-22. PubMed ID: 8406354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune hepatitis.
    Toda G; Zeniya M
    Intern Med; 1993 Dec; 32(12):913-6. PubMed ID: 8204967
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.